This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Kymera Therapeutics, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Chris De Savi: Innovator in IRAK Degraders
Introduction
Chris De Savi is a notable inventor based in Watertown, MA (US). He has made significant contributions to the field of biochemistry, particularly through his innovative work on IRAK degraders. His research focuses on developing compounds and compositions that have practical applications in various therapeutic areas.
Latest Patents
Chris De Savi holds one patent titled "IRAK degraders and uses thereof." This patent provides detailed information about the compounds, compositions, and methods of using these innovative substances. His work in this area showcases his commitment to advancing scientific knowledge and improving healthcare solutions.
Career Highlights
Chris is currently employed at Kymera Therapeutics, Inc., where he continues to push the boundaries of research and development. His role at the company allows him to collaborate with other talented scientists and contribute to groundbreaking projects in the field of drug discovery.
Collaborations
Throughout his career, Chris has worked alongside esteemed colleagues such as Nello Mainolfi and Matthew M Weiss. These collaborations have fostered a dynamic research environment that encourages innovation and the sharing of ideas.
Conclusion
In summary, Chris De Savi is a dedicated inventor whose work on IRAK degraders has the potential to make a significant impact in the field of biochemistry. His contributions at Kymera Therapeutics, Inc. and collaborations with fellow researchers highlight his commitment to advancing scientific research and improving therapeutic options.